Topical Brimonidine Tartrate 0.33% Gel on Postlaser Erythema: Our Experience and Review of the Literature.
作者信息
Lee Sang Ju, Kim Hyeree, Kim Hei Sung
机构信息
Yonsei Star Skin and Laser Clinic, Seoul, Korea Department of Dermatology, Incheon St. Mary's Hospital, The Catholic University of Korea, Incheon, Korea.
出版信息
Dermatol Surg. 2018 Jan;44(1):144-147. doi: 10.1097/DSS.0000000000001389.
PMID:29077635
Abstract
摘要
相似文献
1
Topical Brimonidine Tartrate 0.33% Gel on Postlaser Erythema: Our Experience and Review of the Literature.
Dermatol Surg. 2018 Jan;44(1):144-147. doi: 10.1097/DSS.0000000000001389.
2
Topical brimonidine tartrate 0·33% gel effectively reduces the post-treatment erythema of daylight-activated photodynamic therapy.0.33%酒石酸溴莫尼定外用凝胶可有效减轻日光激活光动力治疗后的红斑。
Br J Dermatol. 2016 Jun;174(6):1422-3. doi: 10.1111/bjd.14384. Epub 2016 Mar 31.
3
Brimonidine tartrate 0.33% gel for the management of posttreatment erythema induced by laser skin resurfacing.0.33%酒石酸溴莫尼定凝胶用于治疗激光皮肤磨削术后红斑。
J Am Acad Dermatol. 2017 Feb;76(2):e53-e55. doi: 10.1016/j.jaad.2016.10.020.
4
Image Gallery: Brimonidine gel for facial erythema in Netherton syndrome.
Br J Dermatol. 2018 Apr;178(4):e277. doi: 10.1111/bjd.16355.
5
Brimonidine gel 0.33% rapidly improves patient-reported outcomes by controlling facial erythema of rosacea: a randomized, double-blind, vehicle-controlled study.0.33%溴莫尼定凝胶通过控制酒渣鼻的面部红斑迅速改善患者报告的结局：一项随机、双盲、赋形剂对照研究。
J Eur Acad Dermatol Venereol. 2015 Dec;29(12):2405-10. doi: 10.1111/jdv.13305. Epub 2015 Sep 28.
6
Allergic contact dermatitis to topical brimonidine.外用溴莫尼定引起的变应性接触性皮炎。
Australas J Dermatol. 2015 Aug;56(3):235. doi: 10.1111/ajd.12299.
7
Efficacy and safety of once-daily topical brimonidine tartrate gel 0.5% for the treatment of moderate to severe facial erythema of rosacea: results of two randomized, double-blind, and vehicle-controlled pivotal studies.每日一次外用0.5%酒石酸溴莫尼定凝胶治疗中度至重度酒渣鼻面部红斑的疗效和安全性：两项随机、双盲、赋形剂对照关键研究的结果
J Drugs Dermatol. 2013 Jun 1;12(6):650-6.
8
Once-daily topical brimonidine tartrate gel 0·5% is a novel treatment for moderate to severe facial erythema of rosacea: results of two multicentre, randomized and vehicle-controlled studies.每日一次局部应用酒石酸溴莫尼定凝胶 0.5%是治疗中重度酒渣鼻面部红斑的一种新方法：两项多中心、随机对照和赋形剂对照研究的结果。
Br J Dermatol. 2012 Mar;166(3):633-41. doi: 10.1111/j.1365-2133.2011.10716.x.
9
Brimonidine gel for the treatment of recalcitrant facial erythema in diseases other than rosacea: a novel tool for clinicians.溴莫尼定凝胶用于治疗玫瑰痤疮以外疾病的顽固性面部红斑：临床医生的新工具
J Eur Acad Dermatol Venereol. 2017 Jan;31(1):e32-e33. doi: 10.1111/jdv.13618. Epub 2016 Mar 16.
10
Allergic contact dermatitis caused by Mirvaso®, brimonidine tartrate gel 0.33%, a new topical treatment for rosaceal erythema.酒渣鼻红斑的新型局部治疗药物——0.33%酒石酸溴莫尼定凝胶（Mirvaso®）引起的变应性接触性皮炎。
Contact Dermatitis. 2015 Dec;73(6):366-7. doi: 10.1111/cod.12476.
引用本文的文献
1
A Randomized Controlled Trial on the Effectiveness of Epidermal Growth Factor-Containing Ointment on the Treatment of Solar Lentigines as Adjuvant Therapy.表皮生长因子乳膏辅助治疗日光性黑子的随机对照试验
Medicina (Kaunas). 2021 Feb 13;57(2):166. doi: 10.3390/medicina57020166.
2
Update on the Management of Rosacea from the American Acne & Rosacea Society (AARS).美国痤疮与玫瑰痤疮协会（AARS）发布的玫瑰痤疮管理最新情况。
J Clin Aesthet Dermatol. 2020 Jun;13(6 Suppl):S17-S24. Epub 2020 Jun 1.
3
Update on the Management of Rosacea from the American Acne & Rosacea Society (AARS).美国痤疮与酒渣鼻协会（AARS）发布的酒渣鼻管理最新情况。
J Clin Aesthet Dermatol. 2019 Jun;12(6):17-24. Epub 2019 Jun 1.
Zotero 插件